Mohamed Issa

‘If it’s like this, I don’t do it anymore’ (angry stomping) Practicing energy tools for ourselves can sometimes feel that it is failing us. Whether these are for protection, healing, balance, intention setting, realizing our goals etc. it applies to all A/ it is normal, we all go through it, ans some of us are more patient than others. It happened to me many times and that’s then the frustrated and angry Emilie reaction 👆😂 B/ it may not be true that it is failing us, we just don’t see the bigger picture yet. Jeffrey Allen is explaining this very nicely in the below 👇 and giving very helpful tips for when you are in such a situation. Worth watching for those of you that are practicing. Enjoy and keep going! 🌞 #energyhealing #energymanagement #energycoaching

6

This content is intended for U.S. audiences only. The countdown to Chicago is on, as we gear up for #ASCO24 in less than two weeks! For the first time, @AstraZeneca will headline not one, but TWO back-to-back plenary sessions in LUNG as well as a late-breaking study in BREAST. Our team is focused on treating cancers at earlier stages and across subtypes while advancing medicines and combination therapies that attack the disease from all angles, evidenced by our strong, diverse research to be presented in Chicago. Behind every data point is a patient, who deserves a personalised therapy that will give them a longer and healthier life. For each one, we’re pushing the boundaries of science, and I can’t wait to highlight our research advances in the coming weeks. Stay tuned! 🔬 For a more detailed preview of our #ASCO24 data presentations, please see our press release https://lnkd.in/ehH7tqFc #CancerResearch #oncology #MedicalAdvancements

224

3 Comments

"IQVIA estimates that the dearth of a Humira (adalimumab) biosimilars last year cost patients and employers cumulatively $6 billion." #Biosimilars #Adalimumab like #Hulio from #BioconBiologics can provide #affordable #access to #patients and save billions for the Government. #Biosimilars are the way forward for affordable biologics therapy. Read the article: US Specific "The biosimilar Hulio was offered last year at a WAC of $498 for a month's supply, versus $3,461 for Humira, according to a Samsung Bioepis biosimilar report. Still, the vast majority of prescriptions filled in 2023 were for the Humira originator product, prompting market research group IQVIA to conclude that “maintaining patients on Humira comes at a cost of up to about $6 billion per year for patients and employers, compared to a full transition to adalimumab biosimilars.” Biocon Biologics Matt Erick Joshua Salsi https://lnkd.in/gN74FShF

33

I will be participating in the community roundtable on drug shortages and the supply chain at 11 AM, and attending the session on environmental considerations across the life cycle at 10 AM. Looking forward to hearing perspectives on efforts to improve the eco-impact of manufacturing especially because in 2025, US Pharmacopeia will launch a pillar of our 2025-2030 strategy to develop and revise USP public quality standards to reduce the environmental footprint of pharma manufacturing. We’ll be looking at natural resource usage in quality assurance, chemicals of concern, animal products used in quality assurance, and other ways to reduce environmental impact while maintaining quality. To succeed, we will need the collaboration of regulators, and importantly, the pharma industry. We hope you will share the many advances in ‘greening’ the supply chain so that they can be incorporated into USP standards to broaden their usage in the US and around the world. This is all about impact for the planet and human health. #DIA2024

17

In 2020, the AbbVie Foundation embarked on a journey with the UChicago Medicine’s Urban Health Initiative (UHI) to launch the Liaisons in Care (LinC) program to reduce health disparities in marginalized communities. Fast forward four years, today, our Corporate Responsibility & Global Philanthropy Team had the honor of welcoming the LinC Team to our HQ to celebrate our progress and discuss the challenges and opportunities for continuing to advance health equity. Since launching on Chicago’s South Side—a community grappling with some of the worst economic, health, social, and violence outcomes in the United States due to generations of structural inequality and neglect that have eroded essential social, economic, and health-promoting infrastructure—LinC’s community health workers and partnerships have assisted over 27,000 residents in navigating care and accessing vital health and social services, resulting in measurable improvements in health outcomes. As Dr. Martin Luther King Jr. said, “Of all the forms of inequality, injustice in health is the most shocking and inhuman.” We need to recognize that health inequities affect us all, and together, we must advocate for a future where everyone has access to the care they need.

107

5 Comments

AbbVie’s latest profit forecast for 2024 is up, thanks to strong sales of its immunology drugs, Skyrizi and Rinvoq. Skyrizi is expected to hit $11 billion in sales, and Rinvoq $5.7 billion, surpassing earlier projections and helping offset revenue losses from its former bestseller, Humira, which faces competition from generics. However, challenges remain as AbbVie now contends with pricing pressures on Imbruvica due to Medicare negotiations. This shift marks both growth opportunities and strategic challenges for AbbVie in the evolving healthcare landscape. #PharmaInnovation #ImmunologyAdvances #AbbVieGrowth #HealthcareLeadership https://lnkd.in/ecK24Dh8

1

I love this work led by US Pharmacopeia Council of Experts member Jane Weitzel. Supporting systems than ensure the quality of medicines is clearly in the interest of patient and public health on its face but, if you consider the application of this work across 22,000 drug manufacturing sites around the world, the impact on planet health is also clear. And, another bonus …. using fewer natural resources also reduces costs and saves money. Win for patients, win for the planet, and a win for industry! A trifecta of impact.

46

Hahahaha - oh, this is rich. The mission statement from one of the priciest consulting groups around. And the audacity to open it up with, OUR MISSION IS CLEAR: Our mission is clear. We go deep to unlock insight and have the courage to act. We bring the right people together to challenge established thinking and drive transformation. We work with our clients to build the capabilities that enable organizations to achieve sustainable advantage. We are shaping the future. Together. (translation: we trade lotsa jargon for lotsa dollars)

2

2 Comments

Prevention is the key to healthy aging. Thanks to Dr. Leonard Friedland for discussing this critical topic with PhRMA CMO Michael Ybarra, MD and how the biopharmaceutical industry is focused on fighting disease before it takes hold. https://lnkd.in/evuu8imS

6

Healthy living to prevent cancer or support recovery involves a holistic approach that emphasizes nutrition, physical activity, mental wellness, and lifestyle adjustments. A holistic approach to cancer prevention and recovery can be powerful, especially when tailored to individual needs and preferences. By combining healthy choices with regular medical screenings and mental wellness practices, you can build a strong foundation for health.

7

Rules of Patient Engagement 2024. What would you add? Follow us at DontBePatient Intelligence to see examples of how we do it.

6

Join us on Wednesday, July 24 at 8:30 a.m. EDT for Mind the Gap: The Cost of Mental Health Disparities, a live discussion hosted by The Hill and sponsored by Otsuka. One in five U.S. adults live with a mental illness, yet access to treatment remains a challenge. This is especially true for lower-income individuals and minority populations who bear a disproportionate burden of both mental health and chronic conditions. According to the National Alliance on Mental Illness (NAMI), Non-Hispanic White adults (52%) are more than twice as likely to receive treatment for a mental illness compared to Asian Americans (25%). Those numbers increase modestly among the Hispanic or Latino (36%) and Black or African American (39%). What barriers prevent racial and ethnic minority groups, as well as other marginalized, rural, and under-resourced populations, from accessing treatment? What are the unique mental health needs of racially and ethnically diverse communities? What is the economic cost of not investing in mental health services, treatments, and programs? How can we change the conversation around minority mental health to reduce stigma and encourage more integrated, equitable care? In honor of Minority Mental Health Awareness Month, the Hill will bring together lawmakers, mental health experts and advocates to discuss these questions and more as they discuss the findings of the Meharry School of Global Health’s 2024 study, “The Projected Costs and Economic Impact of Mental Health Inequities in the United States.” Register for the event: https://bit.ly/4bzELN9 https://dy.si/m77o8

9

The Mysteries of Psychosomatic Illnesses I had an enlightening conversation with Dr. Vibha about psychosomatic illnesses, where we reveal how our mental state significantly impacts our #physicalhealth. Dr. Vibha explains the powerful influence of our #mindset on overcoming chronic conditions and the simple, yet effective treatments that can make all the difference. If you’ve ever wondered how stress and your thoughts can manifest into physical symptoms, this video is a must-watch! ➡️ Have you experienced the effects of psychosomatic illnesses? Share your stories and insights below! PS: watch the full video link in comment 👇 _________________ Follow Punit Bansal for more on #holisticsuccess #entrepreneurship #spirituality

25

4 Comments

Still feeling energized from joining my colleagues, advocacy partners, and industry peers at the American Transplant Congress (ATC) 2024!   Kidney transplantation offers several benefits over dialysis, yet only about 3% of people in the U.S. with incident end-stage renal disease receive a #KidneyTransplant preemptively, meaning before starting dialysis. This proactive approach may help improve outcomes and quality of life for some patients with end-stage renal disease.   Part of this challenge stems from the shortage of available kidneys, and by the lengthy waiting time for a kidney from a deceased donor, averaging 3-5 years.   My colleague, Dr. Troy Somerville, Head, US Medical Transplant Unit at Sanofi, shares more on preemptive transplantation and the critical need for kidneys from living donors to address the shortage.   Explore firsthand accounts from kidney recipients and donors at https://lnkd.in/eANNgKj3.   #Pledge2Reflect

31

1 Comment

When our purpose aligns, we transform collective ambition into groundbreaking medical innovations and unparalleled patient care.

12

Very interesting move by J&J with TREMFYA in PsO.  With these Phase IIIb SPECTREM study data, J&J was able to show Tremfya (guselkumab) achieved a 74.2% clearance rate in patients with low BSA psoriasis affecting special sites like the scalp, face, skin folds, and genitals, compared to 12.4% for placebo. These patients are often less likely to receive systemic biologics (versus topicals) since their psoriasis is covering less surface area. Nevertheless, the psoriasis can be uncomfortable based on the location affected. This move could potentially increase the size of the biologic treatment "pie". It will be interesting to see how the FDA and insurers react to this option for patients. It will also be interesting to see how competitors respond if this tactic proves successful. Stay tuned! #psoriasis #clinicaldata #dermatology

3

When nearly half of the public and a third of health policymakers are unable to identify chronic obstructive pulmonary disease (COPD) as a lung disease, it’s time to Speak Up. This disease can be debilitating and impacts an est. 391M people, creating burdens on their families and health systems around the world. Action is needed. We can be the catalyst. At AstraZeneca we’re proud to be founding members of the influential campaigning coalition, Speak Up for COPD. Today alongside our partners, we’re launching The Global State of COPD Report, which provides policymakers with a solutions framework and best practices to transform care for people with COPD. We need you to #SpeakUpforCOPD and bring it to the top of policy agendas. Check out the report, share it, lend your voice, create change: https://lnkd.in/dmwvhiwn

25